ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

INBX Inhibrx Biosciences Inc

14.19
0.00 (0.00%)
Pre Market
Last Updated: 09:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)
Total Revenue 0100k0
Operating Income -49.21M-185.51M-46.8M
Pre Tax Income -49.27M1.83B-43.86M
Net Income -49.27M1.83B-43.86M
Preferred Dividends 000
Basic Earnings Per Share (EPS) 000
EBIT -49.27M1.84B-46.78M
EBITDA -48.85M-185.03M-46.04M
Year End 31 December 2023 20222023
USD (US$)USD (US$)
Total Revenue 1.32M1.63M
Operating Income -115.32M-152.75M
Pre Tax Income -115.32M-154.96M
Net Income -115.33M-154.96M
Preferred Dividends 00
Basic Earnings Per Share (EPS) -47.071-63.251
EBIT -115.32M-153.33M
EBITDA -114.1M-151.56M

Your Recent History

Delayed Upgrade Clock